This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Richter Gedeon Nyrt.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: József Levente Petro: Innovator in Pharmaceutical Chemistry
Introduction
József Levente Petro is a notable inventor based in Szazhalombatta, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thiadiazine derivatives. His research focuses on the development of compounds that can modulate the activity of the α7 nicotinic acetylcholine receptor, which is crucial for various biological processes.
Latest Patents
József holds a patent for thiadiazine derivatives, which includes pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates, and hydrates. This invention is particularly relevant for its potential applications in pharmaceutical compositions aimed at enhancing receptor activity in mammalian subjects. The patent showcases his expertise in creating compounds that could lead to advancements in medical treatments.
Career Highlights
József is associated with Richter Gedeon Nyrt., a prominent pharmaceutical company in Hungary. His work at the company has allowed him to apply his innovative ideas in a practical setting, contributing to the development of new therapeutic solutions. His dedication to research and development has positioned him as a key figure in his field.
Collaborations
Throughout his career, József has collaborated with esteemed colleagues such as György István Lévay and István Ledneczki. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research efforts.
Conclusion
József Levente Petro is a distinguished inventor whose work on thiadiazine derivatives exemplifies the intersection of innovation and pharmaceutical science. His contributions continue to influence the development of new therapeutic agents, showcasing the importance of research in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
